Skip to main content

A Multicenter, Double-Blind, Placedbo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG0002) on reducing Infarct volume in Acute Ischemic Stroke.

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Neurocritical Care

Awarded By

Biogen Idec Inc.

Start Date

November 1, 2013

End Date

May 31, 2015
 

Administered By

Neurology, Neurocritical Care

Awarded By

Biogen Idec Inc.

Start Date

November 1, 2013

End Date

May 31, 2015